Literature DB >> 15833368

Autoantibodies against the amino terminal of alpha-enolase are a useful diagnostic marker of Hashimoto's encephalopathy.

A Fujii1, M Yoneda, T Ito, O Yamamura, S Satomi, H Higa, A Kimura, M Suzuki, M Yamashita, T Yuasa, H Suzuki, M Kuriyama.   

Abstract

We investigated autoantibodies and their epitope(s) in Hashimoto's encephalopathy associated with Hashimoto's thyroiditis. In a proteomic analysis, they proved to recognize alpha-enolase. We further searched the epitope region in alpha-enolase using different regions of recombinant proteins expressed in cultured human cells. The amino terminal region was recognized by autobodies from a much higher proportion of patients with Hashimoto's encephalopathy (83.3%; 5/6) than from patients with Hashimoto's thyroiditis (11.8%; 2/17), and not at all by sera from controls (25 healthy individuals and 25 controls with other neurological disorders) (0%; 0/50). Neither the carboxyl terminal nor the mid-region of alpha-enolase showed specificity for Hashimoto's encephalopathy. Autoantibodies against the amino terminal of alpha-enolase are a useful diagnostic marker for Hashimoto's encephalopathy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15833368     DOI: 10.1016/j.jneuroim.2005.02.004

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  31 in total

1.  Externalized glycolytic enzymes are novel, conserved, and early biomarkers of apoptosis.

Authors:  David S Ucker; Mohit Raja Jain; Goutham Pattabiraman; Karol Palasiewicz; Raymond B Birge; Hong Li
Journal:  J Biol Chem       Date:  2012-01-18       Impact factor: 5.157

Review 2.  Clinical and diagnostic aspects of encephalopathy associated with autoimmune thyroid disease (or Hashimoto's encephalopathy).

Authors:  Gianluca Tamagno; Giovanni Federspil; Giovanni Murialdo
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

Review 3.  The neurological disorder associated with thyroid autoimmunity.

Authors:  Franco Ferracci; Antonio Carnevale
Journal:  J Neurol       Date:  2006-06-19       Impact factor: 4.849

4.  Hashimoto's encephalopathy presenting with progressive cerebellar ataxia.

Authors:  H Nakagawa; M Yoneda; A Fujii; K Kinomoto; M Kuriyama
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-02       Impact factor: 10.154

Review 5.  Hashimoto's encephalopathy : epidemiology, pathogenesis and management.

Authors:  Ramon Mocellin; Mark Walterfang; Dennis Velakoulis
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

6.  A case of Hashimoto encephalopathy in a Malay woman with Graves disease.

Authors:  Chai Soon Ngiu; Norlinah M Ibrahim; Wan Nur Nafisah Wan Yahya; Hui Jan Tan; Norlaila Mustafa; Hamidon Basri; Raymond Azman Ali
Journal:  BMJ Case Rep       Date:  2009-06-26

7.  Hashimoto encephalopathy presenting with progressive cerebellar ataxia.

Authors:  H Nakagawa; M Yoneda; A Fujii; K Kinomoto; M Kuriyama
Journal:  BMJ Case Rep       Date:  2009-07-07

8.  HAUSP regulates c-MYC expression via de-ubiquitination of TRRAP.

Authors:  Seemana Bhattacharya; Mrinal K Ghosh
Journal:  Cell Oncol (Dordr)       Date:  2015-04-30       Impact factor: 6.730

9.  Successful response to intravenous immunoglobulin as rescue therapy in a patient with Hashimoto's encephalopathy.

Authors:  Rodrigo Cornejo; Pablo Venegas; Daniela Goñi; Alvaro Salas; Carlos Romero
Journal:  BMJ Case Rep       Date:  2010-12-29

Review 10.  Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT): case report of reversible coma and status epilepticus in an adolescent patient and review of the literature.

Authors:  Johannes M Hilberath; Heinrich Schmidt; Gerhard K Wolf
Journal:  Eur J Pediatr       Date:  2014-08-02       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.